Company Selected - Sino Biopharmaceutical Ltd - Solvency
| Fiscal Year is From January To December | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | View Chart |
|---|---|---|---|---|---|
| Debt To Assets Ratio | 15.85% | 11.85% | 14.83% | 11.78% | |
| Equity To Assets Ratio | 61.12% | 61.12% | 65.40% | 65.40% | |
| Debt To Capital Ratio | 26.24% | 21.00% | 23.28% | 19.42% | |
| Debt To Equity Ratio | 0.3557x | 0.2659x | 0.3035x | 0.241x | |
| Financial Leverage Ratio | 2.15x | 2.10x | 2.04x | 2.05x | |
| EBIT Interest Coverage | 8.99x | 8.07x | 8.90x | 6.04x | |
| EBITDA Interest Coverage | 10.75x | 9.62x | 10.54x | 7.06x | |
| Funds From Operation To Total Debt | 26.62% | 35.16% | 33.75% | 118.70% | |
| Total Debt To EBITDA | 1.96x | 1.50x | 1.54x | 1.57x | |
| Altman Z-Score | 3.23 | 2.59 | 2.96 | 3.04 |